Research Article

Prognostic Value of Invasion, Markers of Proliferation, and Classification of Giant Pituitary Tumors, in a Georeferred Cohort in Brazil of 50 Patients, with a Long-Term Postoperative Follow-Up

Table 1

Used antibodies, clones, and dilutions.

Antibodies (all Dako Corporations products)ClonesDilution

Anti-PRLPolyclonal1 : 2000
Anti-GHPolyclonal1 : 2000
Anti-FSHC101 : 50
Anti-LHC931 : 50
Anti-ACTHO2A31 : 100
Anti-TSH421 : 50
p53DO71 : 100
Ki-67MIB 11 : 100
c-erbB2Oncoprotein C1 : 400